• US induced membrane potential changes in SHSY5Y cells. • US increased c-fos level in ventral tegmental area of mouse brains. • US activated dopaminergic neurons in substantia nigra and ameliorated the dopaminergic neurodegeneration in Parkinson's disease mice. • US mitigated the motor symptoms of Parkinson's disease mice. This evidence concerns the gene FOS and Parkinson disease.